Higher doses increase the chances of high hemoglobin. There are many ways to reduce risks while continuing therapy. While some people feel normal even if their hemoglobin rises, others may feel symptoms. Most people can stay safely on TRT as long as they check their labs and follow the treatment plan. This can increase the strain on the heart and raise the chances of blood pressure changes or clot formation.
Hematocrit rises when the number of red blood cells increases or when the plasma volume decreases (such as with dehydration). These checks usually include a complete blood count, or CBC, which measures hemoglobin, hematocrit, and red blood cell count. Testosterone can increase a hormone called erythropoietin, or EPO, which signals the bone marrow to make more red blood cells. Many people starting TRT do not know that testosterone is tied closely to red blood cell production. Testosterone has a strong effect on how many red blood cells your body makes. When larger doses of injectable testosterone block hepcidin, more iron is released and absorbed into the body. The study concluded that the rise in hematocrit or blood thickness, is related to the supression of hepcidin caused by high dose injectable testosterone.
Serum hepcidin was measured by enzyme-linked immunosorbent assay (Intrinsic Life Sciences) with sensitivity of 5ng/mL, interassay coefficient of variation 12%, and range 29–254ng/mL in men (12,15). Free testosterone was calculated from total testosterone and SHBG concentrations using a published law-of-mass-action equation (14). At the time of trial’s cessation, 209 men had been randomized and 166 had completed 6 months of study intervention; these 166 men constituted the analytic sample for this investigation.
Research shows that blood donors using TRT donate more often than other blood donors. Some people felt dizzy or faint, but not more than expected in a group of people being stuck with needles. Another study showed a low risk of side effects. Just two percent said the treatment made them feel worse. However, you might need multiple sessions to bring your hematocrit within the target range. Therapeutic phlebotomy is highly effective for quickly reducing hematocrit in men on TRT, says Calvert. The session might feel like a cross between a blood test and a blood donation.
They should take a baseline hematocrit measurement as part of your workup before beginning TRT, says Calvert. The other is your individual mix of risk factors, like smoking, sleep apnea, or chronic obstructive pulmonary disease (COPD), that add to your risk of a dangerous clot, says Calvert. One is how high your hematocrit goes before you catch it and bring it down. High hematocrit can cause serious problems for your heart and circulatory system, so it’s important to consistently monitor your level with your prescriber. There are two types of polycythemia.
It was discovered in 2000, and is now known to be the master regulator of iron metabolism in the body. The study results showed that within one week of getting the testosterone injections at higher doses, a substance called hepcidin was markedly suppressed in the men. The men’s own testosterone production was purposely supressed by providing them with a drug that blocks the secretion of gonadatrophic releasing hormone (GRH), which controls testosterone production in the body. While the relationship between testosterone replacement therapy (TRT) and cardiovascular disease (CVD)  is specious at best, there is one effect of testosterone that could cause problems in this area. The reasons for the reluctance of physicians to treat low testosterone levels in men has to do with the notion that testosterone levels are related to both the onset of prostate cancer, as well as adverse cardiovascular effects. This is true even for men with clinically proven low testosterone levels. It’s difficult for men to be treated for low testosterone levels for a number of reasons.
While TRT can help with these symptoms, it also affects many systems in the body. Many people use TRT to improve symptoms such as low energy, decreased muscle strength, low libido, and trouble with mood or concentration.
In polycythemia, it is likely the increase in platelets that is the major culprit of blood clots. If the hematocrit percentage drops to less than 50%, and no other secondary causes of erythrocytosis are found, testosterone can be restarted at lower doses.3 In addition to monitoring of hematocrit percentage during testosterone replacement, physicians should reevaluate indications for testosterone to ensure that patients are receiving clinical benefit, warranting ongoing treatment. Recent understanding of hematopoiesis shows that estradiol, an aromatized form of testosterone, is responsible for an increase in hematopoietic stem cell proliferation and survival. Trends for hemoglobin level (red line) and hematocrit percentage (blue line) in a 65-year-old man receiving testosterone supplementation for perceived androgen deficiency. Moreover, our patient’s serum erythropoietin level was inappropriately normal at 9.6 (normal 3.8–16.9) IU/L, which further supported that a secondary process was causing elevated hemoglobin and hematocrit through an erythropoietin-dependent mechanism.
But TRT also affects your blood system, especially your hemoglobin and hematocrit levels. One of the most important safety issues during testosterone therapy is the rise in hemoglobin and hematocrit. But TRT also affects how your body makes red blood cells.